Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus

AIDS Research and Human Retroviruses

Volumn 15, Issue 4, 1999, Pages 391-394

  Joag, Sanjay V ^a   Li, Zhuang ^a   Wang, Chunyang ^a   Foresman, Larry ^a   Jia, Fenglan ^a   Stephens, Edward B ^a   Zhuge, Wu ^a   Narayan, Opendra ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEUTRALIZING ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

AIDS VACCINES; ANIMALS; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNIZATION, PASSIVE; MACACA NEMESTRINA; MUCOUS MEMBRANE; NEUTRALIZATION TESTS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033045486     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311367     Document Type: Article

References (20)

1. Eichberg JW, Murthy KK, Ward RH, and Prince AM: Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG. AIDS Res Hum Retroviruses 1992;8:1515.
2. Emini EA, Schleif WA, Nunberg JH, Conley AJ, Eda Y, Tokiyoshi S, Putney SD, Matsushita S, Cobb KE, Jett CM, et al.: Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature (London) 1992;355:728-730.
3. Conley AJ, Kessler AJ II, Boots LJ, McKenna PM, Schleif WA, Emini EA, Mark GE III, Katinger H, Cobb EK, Lunceford SM, Rouse SR, and Murthy KK: The cosequence of passive administration of an anti-human immunodeficiency virus type 1 nuetralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J Virol 1996;71:6751-6758.
4. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD, and Alexander NJ: Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996;2:1084-1089.
5. + T cells, and AIDS. J Virol 1997;71:4016-4023.
6. Foresman L, Jia F, Li Z, Wang C, Stephens EB, Sahni M, Narayan O, and Joag SV: Neutralizing antibodies administered before but not after virulent SHIV prevent infection in macaques. AIDS Res Hum Retroviruses 1998;14:1035-1043.
7. Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AJ, Rusche JR, Bolognesi DP, Putney SD, and Matthews TJ: Principal neutralizing domain of the HIV type 1 envelope protein. Proc Natl Acad Sci USA 1989;86:6768-6772.
8. Hwang SS, Boyle TJ, Lyerly HK, and Cullen BR: Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 1992;257:535-537.
9. Li J, Lord CI, Haseltine W, Letvin NL, and Sodroski J: Infection of cynomologus monkeys with a chimeric HIV-1/SIVmacX virus that expresses the HIV-1 envelope glycoproteins. J AIDS 1992;5: 639-646.
10. + T cell loss and AIDS in rhesus macaques. J Med Primatol 1998; 14:1045-1051.
11. Joag SV, Li Z, Foresman L, Pinson D, Raghavan R, Zhuge W, Adany I, Wang C, Jia F, Sheffer D, Ranchalis J, Watson A, and Narayan O: Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses 1997;13:635-645.
12. mac infection in Chinese and Indian rhesus macaques: Effects of splenectomy on virus burden. Virology 1994; 200:436-446.
13. Lennette EH: General principles underlying laboratory diagnosis of viral and rickettsial infections. In Diagnostic Procedures for Viral and Rickettsial Infections (Lennette EH and Schmidt NJ, eds.). American Public Health Association, New York, 1969, pp. 1-65.
14. Joag SV, Li Z, Foresman L, Stephens EB, Zhao LJ, Adany I, Pinson DM, McClure HM, and Narayan O: Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4 T cells and AIDS in pigtailed macaques. J Virol 1996;70:3189-3197.
15. Yoshiyama H, Mo H, Moore JP, and Ho DD: Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop. J Virol 1994;68:974-978.
16. Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, and Goudsmit J: Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol 1990;64:3779-3791.
17. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, and Ho DD: Cellular targets of infection and route of viral dissemination after intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183: 215-225.
18. Miller CJ, Vogel P, Alexander NJ, Dandekar S, Hendrickx AG, and Marx PA: Pathology and localization of simian immunodeficiency virus in the reproductive tract of chronically infected male rhesus macaques. Lab Invest 1994;70:255-262.
19. Miller CJ, Alexander NJ, Vogel P, Anderson J, and Marx PA: Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J Med Primatol 1992;21:64-68.
20. mac239 during persistent infection in a rhesus macaque. Virology 1993;195:406-412.